Market Overview:
The global clinical research services (CRS) market is expected to grow at a CAGR of 7.8% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of chronic diseases, rising demand for novel therapies and drugs, and growing investments by pharmaceutical and biotechnology companies in R&D activities. The global CRS market is segmented on the basis of type, application, and region. On the basis of type, the market is divided into early phase services, late phase services, and other services. The early phase services segment is further classified into pre-clinical studies Services (PK/PD Studies), Phase I Clinical Trials Services (First-In-Human Studies), Phase II Clinical Trials Services (Proof-Of-Concept Studies), Phase III Clinical Trials Services ( pivotal studies). Late phase service are further classified into post marketing surveillance studies Service(Phase IV clinical trials) And long term safety follow up Service(Phase 5 clinical trials). Other service include contract manufacturing And Contract Research Organizations(CROs)/Contract Development And Manufacturing Organizations(CDMOs)).On the basis of application ,the global CRS Market Is segmented Into cancer ,cardiovascular diseases ,central nervous system disorders Infectious Diseases Metabolic Diseases Other Diseases . Cancer Is estimated To account For The largest share Of The Global cRs Market In 2018 .
 Industry Outlook.svg)
Product Definition:
1. Clinical research services (CRS) are defined as the provision of services that support clinical research, which is the systematic study of human health and disease. This includes activities such as protocol development, patient recruitment and retention, data management, biostatistics, and safety monitoring. Clinical research services are important because they help ensure that clinical trials are conducted safely and efficiently.
Early Phase Services:
The global early phase services market was valued at USD 2.1 billion in 2015 and is expected to grow at a CAGR of XX% over the forecast period. The rising number of clinical trials and increasing demand for CROs to conduct clinical research are anticipated to drive the growth during the forecast period.
In addition, increasing R&D investments by biotechnology.
Late Phase Services:
Late phase services are the last service which is provided in the clinical research process. It refers to all those activities which are done post-marketing surveillance and before product approval. Late phase services include pharmacovigilance (PV), medical device PV, bioavailability studies, ADME & Toxicityology, Pharmacogenomics and Post Marketing Surveillance (PMDS).
Application Insights:
The application segment is divided into cancer, cardiovascular, CNS, infectious diseases, metabolic diseases and other diseases. The cancer segment dominated the global market in 2017 owing to the increasing prevalence of cancer worldwide. According to the World Health Organization (WHO), it was estimated that about 1.6 million new cases were diagnosed in 2012 and about 2.7 million new cases were diagnosed in 2016 globally which increased by around 70% since 2000 when compared with previous estimates given by WHO.
The others application segment includes diabetes, asthma.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of CROs and clinical research organizations, increased funding for clinical trials, better reimbursement scenario, and rising awareness about advanced treatments. Moreover, increasing prevalence of chronic diseases such as cancer is also expected to boost regional growth over the forecast period. Asia Pacific is expected to witness lucrative growth during the forecast period owing to factors such as improving healthcare infrastructure & availability of skilled professionals coupled with growing investments by governments in this region for conducting clinical trials pertaining to various diseases. Furthermore, an increase in outsourcing opportunities due to regulatory reforms across emerging economies will drive regional demand further.
Growth Factors:
- Increasing incidence of chronic diseases: The global prevalence of chronic diseases is increasing at an alarming rate. This is primarily because of the changing lifestyles and dietary habits of people across the world. As a result, there is an increased demand for effective and innovative treatment options, which can only be provided through clinical research services.
- Technological advancements: The field of medical science is constantly evolving with new technological advancements being made every day. This has led to the development of novel therapeutic approaches that can only be tested through clinical research services.
- Growing awareness about clinical trials: There has been a growing awareness among people about the benefits associated with participating in clinical trials. As a result, more and more people are now willing to enroll in such studies, thereby driving demand for CRSs worldwide.
Scope Of The Report
Report Attributes
Report Details
Report Title
Clinical Research Services (CRS) Market Research Report
By Type
Early Phase Services, Late Phase Services, Other Services
By Application
Cancer, Cardiovascular, CNS, Infectious Diseases, Metabolic Diseases, Other Diseases
By Companies
Labcorp, IQVIA, Syneos Health, Parexel, PRA, PPD, CRL, ICON
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
162
Number of Tables & Figures
114
Customization Available
Yes, the report can be customized as per your need.
Global Clinical Research Services (CRS) Market Report Segments:
The global Clinical Research Services (CRS) market is segmented on the basis of:
Types
Early Phase Services, Late Phase Services, Other Services
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Cancer, Cardiovascular, CNS, Infectious Diseases, Metabolic Diseases, Other Diseases
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Labcorp
- IQVIA
- Syneos Health
- Parexel
- PRA
- PPD
- CRL
- ICON
 Market Overview.svg)
Highlights of The Clinical Research Services (CRS) Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Early Phase Services
- Late Phase Services
- Other Services
- By Application:
- Cancer
- Cardiovascular
- CNS
- Infectious Diseases
- Metabolic Diseases
- Other Diseases
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Clinical Research Services (CRS) Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
CRS is a global organization that provides clinical research services to the pharmaceutical, biotechnology, and medical device industries. CRS helps companies conduct clinical trials by providing expertise in study design, data management, and analysis.
Some of the major players in the clinical research services (crs) market are Labcorp, IQVIA, Syneos Health, Parexel, PRA, PPD, CRL, ICON.
The clinical research services (crs) market is expected to register a CAGR of 7.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Clinical Research Services (CRS) Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Clinical Research Services (CRS) Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Clinical Research Services (CRS) Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Clinical Research Services (CRS) Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Clinical Research Services (CRS) Market Size & Forecast, 2018-2028
4.5.1 Clinical Research Services (CRS) Market Size and Y-o-Y Growth
4.5.2 Clinical Research Services (CRS) Market Absolute $ Opportunity
Chapter 5 Global Clinical Research Services (CRS) Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Clinical Research Services (CRS) Market Size Forecast by Type
5.2.1 Early Phase Services
5.2.2 Late Phase Services
5.2.3 Other Services
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Clinical Research Services (CRS) Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Clinical Research Services (CRS) Market Size Forecast by Applications
6.2.1 Cancer
6.2.2 Cardiovascular
6.2.3 CNS
6.2.4 Infectious Diseases
6.2.5 Metabolic Diseases
6.2.6 Other Diseases
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Clinical Research Services (CRS) Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Clinical Research Services (CRS) Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Clinical Research Services (CRS) Analysis and Forecast
9.1 Introduction
9.2 North America Clinical Research Services (CRS) Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Clinical Research Services (CRS) Market Size Forecast by Type
9.6.1 Early Phase Services
9.6.2 Late Phase Services
9.6.3 Other Services
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Clinical Research Services (CRS) Market Size Forecast by Applications
9.10.1 Cancer
9.10.2 Cardiovascular
9.10.3 CNS
9.10.4 Infectious Diseases
9.10.5 Metabolic Diseases
9.10.6 Other Diseases
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Clinical Research Services (CRS) Analysis and Forecast
10.1 Introduction
10.2 Europe Clinical Research Services (CRS) Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Clinical Research Services (CRS) Market Size Forecast by Type
10.6.1 Early Phase Services
10.6.2 Late Phase Services
10.6.3 Other Services
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Clinical Research Services (CRS) Market Size Forecast by Applications
10.10.1 Cancer
10.10.2 Cardiovascular
10.10.3 CNS
10.10.4 Infectious Diseases
10.10.5 Metabolic Diseases
10.10.6 Other Diseases
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Clinical Research Services (CRS) Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Clinical Research Services (CRS) Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Clinical Research Services (CRS) Market Size Forecast by Type
11.6.1 Early Phase Services
11.6.2 Late Phase Services
11.6.3 Other Services
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Clinical Research Services (CRS) Market Size Forecast by Applications
11.10.1 Cancer
11.10.2 Cardiovascular
11.10.3 CNS
11.10.4 Infectious Diseases
11.10.5 Metabolic Diseases
11.10.6 Other Diseases
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Clinical Research Services (CRS) Analysis and Forecast
12.1 Introduction
12.2 Latin America Clinical Research Services (CRS) Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Clinical Research Services (CRS) Market Size Forecast by Type
12.6.1 Early Phase Services
12.6.2 Late Phase Services
12.6.3 Other Services
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Clinical Research Services (CRS) Market Size Forecast by Applications
12.10.1 Cancer
12.10.2 Cardiovascular
12.10.3 CNS
12.10.4 Infectious Diseases
12.10.5 Metabolic Diseases
12.10.6 Other Diseases
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Clinical Research Services (CRS) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Clinical Research Services (CRS) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Clinical Research Services (CRS) Market Size Forecast by Type
13.6.1 Early Phase Services
13.6.2 Late Phase Services
13.6.3 Other Services
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Clinical Research Services (CRS) Market Size Forecast by Applications
13.10.1 Cancer
13.10.2 Cardiovascular
13.10.3 CNS
13.10.4 Infectious Diseases
13.10.5 Metabolic Diseases
13.10.6 Other Diseases
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Clinical Research Services (CRS) Market: Competitive Dashboard
14.2 Global Clinical Research Services (CRS) Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Labcorp
14.3.2 IQVIA
14.3.3 Syneos Health
14.3.4 Parexel
14.3.5 PRA
14.3.6 PPD
14.3.7 CRL
14.3.8 ICON
